Table 2.
CHEMOTHERAPY TREATMENT | DEGREE OF RISK |
---|---|
Hematopoietic stem cell transplantation and total body irradiation Radiotherapy to a field including the ovaries | High risk >80% |
CAF, CMF, CEF x6 30–39 years of age ACx4 >40 years of age | Intermediate risk |
ABVD,CHOP,CVP,AML, ALL CAF, CMF, CEF x6 <30 years of age ACx4 <40 years of age | Lower Risk (<20%) |
Vincristine Methotrexate Fluorouracil |
Very Low or No Risk |
Taxanes Irinotecan Oxaliplatin Monoclonal antibodies Tyrosine kinase inhibitors |
Unknown Risk |
Abbreviations: C, cyclophosphamide 600–1200 mg/m2; A, adriamycin 25–60 mg/m2; F, fluorouracil 600 mg/m2; E, epirubicin 60 mg/m2; M, methotrexate 40 mg/m2; B, bleomycin 10 U/m2; V, vinblastine 6 mg/m2; D, dacarbazine 375 mg/m2; V (O), vincristine 1.2 mg/m2–2 mg; P, prednisolone 40 mg/m2; H, hydroxydaunorubicin 50 mg/m2.